NCT02074384View on ClinicalTrials.gov

Patient and Provider Glucose Reporting Preferences Ambulatory Glucose Profile (AGP)

NACompletedINTERVENTIONAL
Enrollment

161

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

July 31, 2015

Study Completion Date

July 31, 2015

Conditions
Type 1 Diabetes
Interventions
DEVICE

Continuous Glucose Monitor

CGM device for measurement of interstitial glucose on a 24/7 continuous cycle.

DEVICE

Self Monitoring Blood Glucose

Participants will use their own SMBG device.

OTHER

Clinician

Survey of clinicians after study visits

Trial Locations (7)

10032

Columbia University, New York

32308

Larry Deeb, Tallahassee

39564

The Diabetes Center, PLLC, Ocean Springs

48202

Henry Ford, Detroit

55416

Park Nicollet International Diabetes Center, Minneapolis

59101

St. Vincent's, Billings

06511

Eda Cengiz, New Haven

All Listed Sponsors
collaborator

The Leona M. and Harry B. Helmsley Charitable Trust

OTHER

lead

HealthPartners Institute

OTHER

NCT02074384 - Patient and Provider Glucose Reporting Preferences Ambulatory Glucose Profile (AGP) | Biotech Hunter | Biotech Hunter